These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 18584350)

  • 1. Consequences of telomerase inhibition by BIBR1532 on proliferation and chemosensitivity of chondrosarcoma cell lines.
    Parsch D; Brassat U; Brümmendorf TH; Fellenberg J
    Cancer Invest; 2008 Jul; 26(6):590-6. PubMed ID: 18584350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological telomerase inhibition can sensitize drug-resistant and drug-sensitive cells to chemotherapeutic treatment.
    Ward RJ; Autexier C
    Mol Pharmacol; 2005 Sep; 68(3):779-86. PubMed ID: 15939802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telomerase inhibition and telomere targeting in hematopoietic cancer cell lines with small non-nucleosidic synthetic compounds (BIBR1532).
    El Daly H; Martens UM
    Methods Mol Biol; 2007; 405():47-60. PubMed ID: 18369817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted inhibition of telomerase activity combined with chemotherapy demonstrates synergy in eliminating ovarian cancer spheroid-forming cells.
    Meng E; Taylor B; Ray A; Shevde LA; Rocconi RP
    Gynecol Oncol; 2012 Mar; 124(3):598-605. PubMed ID: 22115853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting telomerase activity by BIBR1532 as a therapeutic approach in germ cell tumors.
    Mueller S; Hartmann U; Mayer F; Balabanov S; Hartmann JT; Brummendorf TH; Bokemeyer C
    Invest New Drugs; 2007 Dec; 25(6):519-24. PubMed ID: 17534576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacodynamics of the G-quadruplex-stabilizing telomerase inhibitor 3,11-difluoro-6,8,13-trimethyl-8H-quino[4,3,2-kl]acridinium methosulfate (RHPS4) in vitro: activity in human tumor cells correlates with telomere length and can be enhanced, or antagonized, with cytotoxic agents.
    Cookson JC; Dai F; Smith V; Heald RA; Laughton CA; Stevens MF; Burger AM
    Mol Pharmacol; 2005 Dec; 68(6):1551-8. PubMed ID: 16150933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of cisplatin on telomerase activity and telomere length in BEL-7404 human hepatoma cells.
    Zhang RG; Zhang RP; Wang XW; Xie H
    Cell Res; 2002 Mar; 12(1):55-62. PubMed ID: 11942411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telomerase antagonists GRN163 and GRN163L inhibit tumor growth and increase chemosensitivity of human hepatoma.
    Djojosubroto MW; Chin AC; Go N; Schaetzlein S; Manns MP; Gryaznov S; Harley CB; Rudolph KL
    Hepatology; 2005 Nov; 42(5):1127-36. PubMed ID: 16114043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance to telomerase inhibition by human squamous cell carcinoma cell lines.
    Bojovic B; Crowe DL
    Int J Oncol; 2011 Apr; 38(4):1175-81. PubMed ID: 21305252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consequences of telomerase inhibition and combination treatments for the proliferation of cancer cells.
    Chen Z; Koeneman KS; Corey DR
    Cancer Res; 2003 Sep; 63(18):5917-25. PubMed ID: 14522918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous targeting of telomeres and telomerase as a cancer therapeutic approach.
    Mo Y; Gan Y; Song S; Johnston J; Xiao X; Wientjes MG; Au JL
    Cancer Res; 2003 Feb; 63(3):579-85. PubMed ID: 12566299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telomere length, telomerase activity and telomerase RNA expression in human esophageal cancer cells: correlation with cell proliferation, differentiation and chemosensitivity to anticancer drugs.
    Asai A; Kiyozuka Y; Yoshida R; Fujii T; Hioki K; Tsubura A
    Anticancer Res; 1998; 18(3A):1465-72. PubMed ID: 9673357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BIBR1532, a Selective Telomerase Inhibitor, Enhances Radiosensitivity of Non-Small Cell Lung Cancer Through Increasing Telomere Dysfunction and ATM/CHK1 Inhibition.
    Ding X; Cheng J; Pang Q; Wei X; Zhang X; Wang P; Yuan Z; Qian D
    Int J Radiat Oncol Biol Phys; 2019 Nov; 105(4):861-874. PubMed ID: 31419512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of hepatoma cells resistance to anticancer drugs is correlated to cell proliferation kinetics, telomere length and telomerase activity.
    Chau NP; Deschatrette J; Wolfrom C
    Anticancer Res; 2005; 25(5):3279-85. PubMed ID: 16101139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNAzyme-like activity of hemin-telomeric G-quadruplexes for the optical analysis of telomerase and its inhibitors.
    Freeman R; Sharon E; Teller C; Henning A; Tzfati Y; Willner I
    Chembiochem; 2010 Nov; 11(17):2362-7. PubMed ID: 21031400
    [No Abstract]   [Full Text] [Related]  

  • 16. [Inhibition of telomeres and telomerase. Seeking for new anticancer drugs].
    Raymond E; Faivre S; Dieras V; Von Hoff D
    Bull Cancer; 1997 Dec; 84(12):1123-33. PubMed ID: 9587365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of chemosensitivity to anticancer drugs and telomere length, telomerase activity and telomerase RNA expression in human ovarian cancer cells.
    Kiyozuka Y; Yamamoto D; Yang J; Uemura Y; Senzaki H; Adachi S; Tsubura A
    Anticancer Res; 2000; 20(1A):203-12. PubMed ID: 10769656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telomerase inhibition is a specific early event in salvicine-treated human lung adenocarcinoma A549 cells.
    Liu WJ; Zhang YW; Shen Y; Jiang JF; Miao ZH; Ding J
    Biochem Biophys Res Commun; 2004 Oct; 323(2):660-7. PubMed ID: 15369801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overcoming the immortality of tumour cells by telomere and telomerase based cancer therapeutics--current status and future prospects.
    Kelland LR
    Eur J Cancer; 2005 May; 41(7):971-9. PubMed ID: 15862745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific telomere dysfunction induced by GRN163L increases radiation sensitivity in breast cancer cells.
    Gomez-Millan J; Goldblatt EM; Gryaznov SM; Mendonca MS; Herbert BS
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):897-905. PubMed ID: 17175117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.